Role of macrophage scavenger receptors in atherosclerosis

Immunobiology

Volumn 217, Issue 5, 2012, Pages 492-502

  Kzhyshkowska, Julia ^a,b   Neyen, Claudine ^c,d   Gordon, Siamon ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d EPFL   (Switzerland)

Author keywords

Adhesion; Cholesterol efflux; Endocytosis; Foam cell; Inflammation; Macrophage; Migration; Modified lipoproteins; Scavenger receptor

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; CD14 ANTIGEN; CD16 ANTIGEN; CD36 ANTIGEN; CLUSTERIN; LIPOPROTEIN; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR A;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CELL COMPONENT; CHRONIC INFLAMMATION; DEGRADATION KINETICS; DISEASE COURSE; FOAM CELL; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INTERNALIZATION; LIPID TRANSPORT; LYSOSOME; MACROPHAGE; MEMBRANE TRANSPORT; MOLECULAR MECHANICS; MONOCYTE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN MODIFICATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; HUMANS; LIPOPROTEINS; MACROPHAGES; RECEPTORS, SCAVENGER;

EID: 84858793002     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.02.015     Document Type: Article

References (106)

1. Acton S.L., Scherer P.E., Lodish H.F., Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 1994, 269:21003-21009.
2. Agrawal S., Febbraio M., Podrez E., Cathcart M.K., Stark G.R., Chisolm G.M. Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development. Circulation 2007, 115:2939-2947.
3. An P., Freedman B.I., Hanis C.L., Chen Y.D., Weder A.B., Schork N.J., Boerwinkle E., Province M.A., Hsiung C.A., Wu X., Quertermous T., Rao D.C. Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis. Diabetes 2005, 54:909-914.
4. Bellanger N., Orsoni A., Julia Z., Fournier N., Frisdal E., Duchene E., Bruckert E., Carrie A., Bonnefont-Rousselot D., Pirault J., Saint-Charles F., Chapman M.J., Lesnik P., Le Goff W., Guerin M. Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1675-1681.
5. Brocheriou I., Maouche S., Durand H., Braunersreuther V., Le Naour G., Gratchev A., Koskas F., Mach F., Kzhyshkowska J., Ninio E. Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis. Atherosclerosis 2011, 214:316-324.
6. Brown M.S., Goldstein J.L. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc Natl Acad Sci USA 1979, 76(7):3330-3337.
7. Brown J.M., Swindle E.J., Kushnir-Sukhov N.M., Holian A., Metcalfe D.D. Silica-directed mast cell activation is enhanced by scavenger receptors. Am. J. Respir. Cell Mol. Biol. 2007, 36:43-52.
8. Bujold K., Rhainds D., Jossart C., Febbraio M., Marleau S., Ong.H. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages. Cardiovasc. Res. 2009, 83:457-464.
9. Bull H.A., Brickell P.M., Dowd P.M. Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett. 1994, 351:41-44.
10. Burke B., Lewis C.E. The Macrophage 2002, Oxford University Press, Oxford. second ed.
11. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
12. Chen M., Masaki T., Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol. Ther. 2002, 95:89-100.
13. Chinetti G., Gbaguidi F.G., Griglio S., Mallat Z., Antonucci M., Poulain P., Chapman J., Fruchart J.C., Tedgui A., Najib-Fruchart J., Staels B. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 2000, 101:2411-2417.
14. Connelly M.A., Klein S.M., Azhar S., Abumrad N.A., Williams D.L. Comparison of class B scavenger receptors. CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J. Biol. Chem. 1999, 274:41-47.
15. de Villiers W.J., Fraser I.P., Gordon S. Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. Immunol. Lett. 1994, 43:73-79.
16. De Winther M.P., Van Dijk K.W., Havekes L.M., Hofker M.H. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2000, 20:290-297.
17. De Winther M.P., Gijbels M.J., Van Dijk K.W., Havekes L.M., Hofker M.H. Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis. Int. J. Tissue React. 2000, 22:85-91.
18. El Khoury J., Thomas C.A., Loike J.D., Hickman S.E., Cao L., Silverstein S.C. Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J. Biol. Chem. 1994, 269:10197-10200.
19. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 1993, 268:11811-11816.
20. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., Sharma K., Silverstein R.L. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 2000, 105:1049-1056.
21. Geng Y., Kodama T., Hansson G.K. Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler. Thromb. 1994, 14:798-806.
22. Geng Y.J., Holm J., Nygren S., Bruzelius M., Stemme S., Hansson G.K. Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler. Thromb. Vasc. Biol. 1995, 15:1995-2002.
23. Glass C.K., Witztum J.L. Atherosclerosis. The road ahead. Cell 2001, 104:503-516.
24. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:333-337.
25. Gough P.J., Greaves D.R., Suzuki H., Hakkinen T., Hiltunen M.O., Turunen M., Herttuala S.Y., Kodama T., Gordon S. Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 1999, 19:461-471.
26. Gowen B.B., Borg T.K., Ghaffar A., Mayer E.P. Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors. Matrix Biol. 2000, 19:61-71.
27. Gratchev A., Kzhyshkowska J., Kannookadan S., Ochsenreiter M., Popova A., Yu X., Mamidi S., Stonehouse-Usselmann E., Muller-Molinet I., Gooi L., Goerdt S. Activation of a TGF-β-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-β receptor II. J. Immunol. 2008, 180:6553-6565.
28. Greaves D.R., Gordon S. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J. Lipid Res. 2009, 50(Suppl.):S282-S286.
29. Griffin E., Re A., Hamel N., Fu C., Bush H., McCaffrey T., Asch A.S. A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation. Nat. Med. 2001, 7:840-846.
30. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat. Immunol. 2011, 12:204-212.
31. Harb D., Bujold K., Febbraio M., Sirois M.G., Ong H., Marleau S. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation. Cardiovasc. Res. 2009, 83:42-51.
32. Hartvigsen K., Chou M.Y., Hansen L.F., Shaw P.X., Tsimikas S., Binder C.J., Witztum J.L. The role of innate immunity in atherogenesis. J. Lipid Res. 2009, 50(Suppl.):S388-S393.
33. Herijgers N., De Winther M.P., Van Eck M., Havekes L.M., Hofker M.H., Hoogerbrugge P.M., van Berkel T.J. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice. J. Lipid Res. 2000, 41:1402-1409.
34. Hirano K., Yamashita S., Nakagawa Y., Ohya T., Matsuura F., Tsukamoto K., Okamoto Y., Matsuyama A., Matsumoto K., Miyagawa J., Matsuzawa Y. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ. Res. 1999, 85:108-116.
35. Horvai A., Palinski W., Wu H., Moulton K.S., Kalla K., Glass C.K. Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:5391-5395.
36. Huang M.M., Bolen J.B., Barnwell J.W., Shattil S.J., Brugge J.S. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:7844-7848.
37. Huh H.Y., Pearce S.F., Yesner L.M., Schindler J.L., Silverstein R.L. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996, 87:2020-2028.
38. Iwashima Y., Eto M., Hata A., Kaku K., Horiuchi S., Ushikubi F., Sano H. Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 2000, 277:368-380.
39. Ji Y., Jian B., Wang N., Sun Y., Moya M.L., Phillips M.C., Rothblat G.H., Swaney J.B., Tall A.R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 1997, 272:20982-20985.
40. Karlsson M.C., Guinamard R., Bolland S., Sankala M., Steinman R.M., Ravetch J.V. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 2003, 198:333-340.
41. Kennedy D.J., Kuchibhotla S., Westfall K.M., Silverstein R.L., Morton R.E., Febbraio M. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc. Res. 2011, 89:604-613.
42. Kodama T., Freeman M., Rohrer L., Zabrecky J., Matsudaira P., Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 1990, 343:531-535.
43. Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr. Opin. Lipidol. 1997, 8:275-280.
44. Kruth H.S. Sequestration of aggregated low-density lipoproteins by macrophages. Curr. Opin. Lipidol. 2002, 13:483-488.
45. Kruth H.S., Zhang W.Y., Skarlatos S.I., Chao F.F. Apolipoprotein B stimulates formation of monocyte-macrophage surface-connected compartments and mediates uptake of low density lipoprotein-derived liposomes into these compartments. J. Biol. Chem. 1999, 274:7495-7500.
46. Kruth H.S., Chang J., Ifrim I., Zhang W.Y. Characterization of patocytosis: endocytosis into macrophage surface-connected compartments. Eur. J. Cell Biol. 1999, 78:91-99.
47. Kuchibhotla S., Vanegas D., Kennedy D.J., Guy E., Nimako G., Morton R.E., Febbraio M. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc. Res. 2008, 78:185-196.
48. Kunjathoor V.V., Febbraio M., Podrez E.A., Moore K.J., Andersson L., Koehn S., Rhee J.S., Silverstein R., Hoff H.F., Freeman M.W. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 2002, 277:49982-49988.
49. Kzhyshkowska J. Multifunctional receptor stabilin-1 in homeostasis and disease. ScientificWorldJournal 2010, 10:2039-2053.
50. Kzhyshkowska J., Krusell L. Cross-talk between endocytic clearance and secretion in macrophages. Immunobiology 2009, 214(7):576-593.
51. Kzhyshkowska J., Gratchev A., Brundiers H., Mamidi S., Krusell L., Goerdt S. Phosphatidylinositide 3-kinase activity is required for stabilin-1-mediated endosomal transport of acLDL. Immunobiology 2005, 210:161-173.
52. Kzhyshkowska J., Workman G., Cardo-Vila M., Arap W., Pasqualini R., Gratchev A., Krusell L., Goerdt S., Sage E.H. Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J. Immunol. 2006, 176:5825-5832.
53. Kzhyshkowska J., Gratchev A., Goerdt S. Stabilin-1, a homeostatic scavenger receptor with multiple functions. J. Cell Mol. Med. 2006, 10:635-649.
54. Kzhyshkowska J., Mamidi S., Gratchev A., Kremmer E., Schmuttermaier C., Krusell L., Haus G., Utikal J., Schledzewski K., Scholtze J., Goerdt S. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 2006, 107:3221-3228.
55. Kzhyshkowska J., Gratchev A., Goerdt S. Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomarker Insights 2007, 128-146.
56. Kzhyshkowska J., Gratchev A., Schmuttermaier C., Brundiers H., Krusell L., Mamidi S., Zhang J., Workman G., Sage E.H., Anderle C., Sedlmayr P., Goerdt S. Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis. J. Immunol. 2008, 180:3028-3037.
57. Kzhyshkowska J., Gratchev A., Krusell L., Mamidi S., Riabov V., Zhang J., Workman G., Sage E.H., Goerdt S. Stabilin-1-multifunctional receptor linking endocytosis and secretion in macrophages. Cytokine 2009, 48:34-35.
58. Llorente-Cortes V., Royo T., Juan-Babot O., Badimon L. Adipocyte differentiation-related protein is induced by LRP1-mediated aggregated LDL internalization in human vascular smooth muscle cells and macrophages. J. Lipid Res. 2007, 48:2133-2140.
59. Loboda A., Jazwa A., Jozkowicz A., Molema G., Dulak J. Angiogenic transcriptome of human microvascular endothelial cells: effect of hypoxia, modulation by atorvastatin. Vascul. Pharmacol. 2006, 44:206-214.
60. Love-Gregory L., Sherva R., Sun L., Wasson J., Schappe T., Doria A., Rao D.C., Hunt S.C., Klein S., Neuman R.J., Permutt M.A., Abumrad N.A. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum. Mol. Genet. 2008, 17:1695-1704.
61. Love-Gregory L., Sherva R., Schappe T., Qi J.S., McCrea J., Klein S., Connelly M.A., Abumrad N.A. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum. Mol. Genet. 2011, 20:193-201.
62. Makinen P.I., Lappalainen J.P., Heinonen S.E., Leppanen P., Lahteenvuo M.T., Aarnio J.V., Heikkila J., Turunen M.P., Yla-Herttuala S. Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors. Cardiovasc. Res. 2010, 88:530-538.
63. Manning-Tobin J.J., Moore K.J., Seimon T.A., Bell S.A., Sharuk M., Alvarez-Leite J.I., De Winther M.P., Tabas I., Freeman M.W. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler. Thromb. Vasc. Biol. 2009, 29:19-26.
64. Martens J.H., Kzhyshkowska J., Falkowski-Hansen M., Schledzewski K., Gratchev A., Mansmann U., Schmuttermaier C., Dippel E., Koenen W., Riedel F., Sankala M., Tryggvason K., Kobzik L., Moldenhauer G., Arnold B., Goerdt S. Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J. Pathol. 2006, 208:574-589.
65. Martin-Fuentes P., Civeira F., Recalde D., Garcia-Otin A.L., Jarauta E., Marzo I., Cenarro A. Individual variation of scavenger receptor expression in human macrophages with oxidized low-density lipoprotein is associated with a differential inflammatory response. J. Immunol. 2007, 179:3242-3248.
66. 2. J. Exp. Med. 1998, 188:2257-2265.
67. McMahon H.T., Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2011, 12:517-533.
68. Mietus-Snyder M., Gowri M.S., Pitas R.E. Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation. J. Biol. Chem. 2000, 275:17661-17670.
69. Moore K.J., Freeman M.W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1702-1711.
70. Moore K.J., Kunjathoor V.V., Koehn S.L., Manning J.J., Tseng A.A., Silver J.M., McKee M., Freeman M.W. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J. Clin. Invest. 2005, 115:2192-2201.
71. + monocytes in detoxification of oxidized LDL. FASEB J. 2009, 23:866-874.
72. Mukhopadhyay S., Varin A., Chen Y., Liu B., Tryggvason K., Gordon S. SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens. Blood 2011, 117:1319-1328.
73. Nakagawa-Toyama Y., Yamashita S., Miyagawa J., Nishida M., Nozaki S., Nagaretani H., Sakai N., Hiraoka H., Yamamori K., Yamane T., Hirano K., Matsuzawa Y. Localization of CD36 and scavenger receptor class A in human coronary arteries - a possible difference in the contribution of both receptors to plaque formation. Atherosclerosis 2001, 156:297-305.
74. Neyen C., Pluddemann A., Roversi P., Thomas B., Cai L., van der Westhuyzen D.R., Sim R.B., Gordon S. Macrophage scavenger receptor A mediates adhesion to apolipoproteins A-I and E. Biochemistry 2009, 48:11858-11871.
75. O'Brien K.D., Olin K.L., Alpers C.E., Chiu W., Ferguson M., Hudkins K., Wight T.N., Chait A. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation 1998, 98:519-527.
76. Park S.Y., Jung M.Y., Lee S.J., Kang K.B., Gratchev A., Riabov V., Kzhyshkowska J., Kim I.S. Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages. J. Cell Sci. 2009, 122:3365-3373.
77. Park Y.M., Febbraio M., Silverstein R.L. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest. 2009, 119:136-145.
78. Platt N., Gordon S. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - the mouse's tale. J. Clin. Invest. 2001, 108:649-654.
79. Plourde N.M., Kortagere S., Welsh W., Moghe P.V. Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A. Biomacromolecules 2009, 10:1381-1391.
80. Pluddemann A., Mukhopadhyay S., Gordon S. The interaction of macrophage receptors with bacterial ligands. Expert Rev. Mol. Med. 2006, 8:1-25.
81. Pluddemann A., Neyen C., Gordon S. Macrophage scavenger receptors and host-derived ligands. Methods 2007, 43:207-217.
82. Politz O., Gratchev A., McCourt P.A., Schledzewski K., Guillot P., Johansson S., Svineng G., Franke P., Kannicht C., Kzhyshkowska J., Longati P., Velten F.W., Johansson S., Goerdt S. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem. J. 2002, 362:155-164.
83. Rahaman S.O., Lennon D.J., Febbraio M., Podrez E.A., Hazen S.L., Silverstein R.L. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 2006, 4:211-221.
84. Rothblat G.H., Llera-Moya M., Atger V., Kellner-Weibel G., Williams D.L., Phillips M.C. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 1999, 40:781-796.
85. Santiago-Garcia J., Kodama T., Pitas R.E. The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J. Biol. Chem. 2003, 278:6942-6946.
86. Schledzewski K., Geraud C., Arnold B., Wang S., Grone H.J., Kempf T., Wollert K.C., Straub B.K., Schirmacher P., Demory A., Schonhaber H., Gratchev A., Dietz L., Thierse H.J., Kzhyshkowska J., Goerdt S. Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. J. Clin. Invest. 2011, 121:703-714.
87. Segers F.M., Yu H., Molenaar T.J., Prince P., Tanaka T., van Berkel T.J., Biessen E.A. Design and validation of a specific scavenger receptor class AI binding peptide for targeting the inflammatory atherosclerotic plaque. Arterioscler. Thromb. Vasc. Biol. 2012, 10.1161/ATVBAHA.111.235358.
88. Shimaoka T., Kume N., Minami M., Hayashida K., Kataoka H., Kita T., Yonehara S. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J. Biol. Chem. 2000, 275:40663-40666.
89. Silverstein R.L., Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal. 2009, 2:re3.
90. Silverstein R.L., Li W., Park Y.M., Rahaman S.O. Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis. Trans. Am. Clin. Climatol. Assoc. 2010, 121:206-220.
91. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320:915-924.
92. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., Rayner K.J., Boyer L., Zhong R., Frazier W.A., Lacy-Hulbert A., El Khoury J., Golenbock D.T., Moore K.J. CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 2010, 11:155-161.
93. Stuart L.M., Bell S.A., Stewart C.R., Silver J.M., Richard J., Goss J.L., Tseng A.A., Zhang A., El Khoury J.B., Moore K.J. CD36 signals to the actin cytoskeleton and regulates microglial migration via a p130Cas complex. J. Biol. Chem. 2007, 282:27392-27401.
94. Sun B., Boyanovsky B.B., Connelly M.A., Shridas P., van der Westhuyzen D.R., Webb N.R. Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J. Lipid Res. 2007, 48:2560-2570.
95. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997, 386:292-296.
96. Svensson P.A., Englund M.C., Snackestrand M.S., Hagg D.A., Ohlsson B.G., Stemme V., Mattsson-Hulten L., Thelle D.S., Fagerberg B., Wiklund O., Carlsson L.M., Carlsson B. Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques. BMC Cardiovasc. Disord. 2005, 5:25.
97. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 2010, 10:36-46.
98. Terpstra V., van Amersfoort E.S., van Velzen A.G., Kuiper J., van Berkel T.J. Hepatic and extrahepatic scavenger receptors: function in relation to disease. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1860-1872.
99. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998, 93:241-252.
100. Vollmer E., Brust J., Roessner A., Bosse A., Burwikel F., Kaesberg B., Harrach B., Robenek H., Bocker W. Distribution patterns of apolipoproteins A1, A2, and B in the wall of atherosclerotic vessels. Virchows Arch. A: Pathol. Anat. Histopathol. 1991, 419:79-88.
101. Wang X., Collins H.L., Ranalletta M., Fuki I.V., Billheimer J.T., Rothblat G.H., Tall A.R., Rader D.J. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 2007, 117:2216-2224.
102. Wang J., Geiger H., Rudolph K.L. Immunoaging induced by hematopoietic stem cell aging. Curr. Opin. Immunol. 2011, 23:532-536.
103. Xu Y., Wang J., Bao Y., Jiang W., Zuo L., Song D., Hong B., Si S. Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model. Anal. Biochem. 2010, 400:207-212.
104. Yue P., Chen Z., Nassir F., Bernal-Mizrachi C., Finck B., Azhar S., Abumrad N.A. Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice. PLoS One 2010, 5:e9906.
105. Zhang J., Gratchev A., Riabov V., Mamidi S., Schmuttermaier C., Krusell L., Kremmer E., Workman G., Sage E.H., Jalkanen S., Goerdt S., Kzhyshkowska J. A novel GGA-binding site is required for intracellular sorting mediated by stabilin-1. Mol. Cell Biol. 2009, 29:6097-6105.
106. Zhao Y., Pennings M., Vrins C.L., Calpe-Berdiel L., Hoekstra M., Kruijt J.K., Ottenhoff R., Hildebrand R.B., van der S.R., Jessup W., Le Goff W., Chapman M.J., Huby T., Groen A.K., van Berkel T.J., Van Eck M. Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI. Atherosclerosis 2011, 218:314-322.